Karakaya Cengiz, Guzeloglu-Kayisli Ozlem, Hobbs Rebecca J, Gerasimova Tsilya, Uyar Asli, Erdem Mehmet, Oktem Mesut, Erdem Ahmet, Gumuslu Seyhan, Ercan Deniz, Sakkas Denny, Comizzoli Pierre, Seli Emre, Lalioti Maria D
Division of Reproductive Endocrinology and Infertility, Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven, CT 06510, USA Division of Reproductive Endocrinology and Infertility, IVF Center, Department of Obstetrics and Gynecology, Gazi University Medical School, Ankara 06500 Turkey.
Division of Reproductive Endocrinology and Infertility, Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven, CT 06510, USA Present address: Department of Obstetrics and Gynecology, Ohio State University College of Medicine, Columbus, OH 43210, USA.
Mol Hum Reprod. 2014 Jul;20(7):630-43. doi: 10.1093/molehr/gau024. Epub 2014 Mar 25.
Genes critical for fertility are highly conserved in mammals. Interspecies DNA sequence variation, resulting in amino acid substitutions and post-transcriptional modifications, including alternative splicing, are a result of evolution and speciation. The mammalian follicle-stimulating hormone receptor (FSHR) gene encodes distinct species-specific forms by alternative splicing. Skipping of exon 2 of the human FSHR was reported in women of North American origin and correlated with low response to ovarian stimulation with exogenous follicle-stimulating hormone (FSH). To determine whether this variant correlated with low response in women of different genetic backgrounds, we performed a blinded retrospective observational study in a Turkish cohort. Ovarian response was determined as low, intermediate or high according to retrieved oocyte numbers after classifying patients in four age groups (<35, 35-37, 38-40, >40). Cumulus cells collected from 96 women undergoing IVF/ICSI following controlled ovarian hyperstimulation revealed four alternatively spliced FSHR products in seven patients (8%): exon 2 deletion in four patients; exon 3 and exons 2 + 3 deletion in one patient each, and a retention of an intron 1 fragment in one patient. In all others (92%) splicing was intact. Alternative skipping of exons 2, 3 or 2 + 3 were exclusive to low responders and was independent of the use of agonist or antagonist. Interestingly, skipping of exon 3 occurs naturally in the ovaries of domestic cats--a good comparative model for human fertility. We tested the signaling potential of human and cat variants after transfection in HEK293 cells and FSH stimulation. None of the splicing variants initiated cAMP signaling despite high FSH doses, unlike full-length proteins. These data substantiate the occurrence of FSHR exon skipping in a subgroup of low responders and suggest that species-specific regulation of FSHR splicing plays diverse roles in mammalian ovarian function.
对生育至关重要的基因在哺乳动物中高度保守。种间DNA序列变异导致氨基酸替换和转录后修饰,包括可变剪接,是进化和物种形成的结果。哺乳动物促卵泡激素受体(FSHR)基因通过可变剪接编码不同的物种特异性形式。据报道,北美裔女性中存在人FSHR外显子2跳跃,且与对外源性促卵泡激素(FSH)卵巢刺激反应低下相关。为了确定这种变异是否与不同遗传背景女性的低反应相关,我们在一个土耳其队列中进行了一项盲法回顾性观察研究。根据四个年龄组(<35岁、35 - 37岁、38 - 40岁、>40岁)患者回收的卵母细胞数量,将卵巢反应分为低、中、高。从96名接受控制性卵巢过度刺激后进行IVF/ICSI的女性收集的卵丘细胞显示,7名患者(8%)中有四种可变剪接的FSHR产物:4名患者外显子2缺失;1名患者外显子3缺失,1名患者外显子2 + 3缺失,1名患者保留内含子1片段。在所有其他患者(92%)中剪接是完整的。外显子2、3或2 + 3的可变跳跃仅见于低反应者,且与使用激动剂或拮抗剂无关。有趣的是,外显子3跳跃在家猫卵巢中自然发生——这是人类生育的一个良好比较模型。我们在HEK293细胞中转染并经FSH刺激后测试了人和猫变异体的信号传导潜力。与全长蛋白不同,尽管FSH剂量很高,但没有一个剪接变异体启动cAMP信号传导。这些数据证实了低反应者亚组中存在FSHR外显子跳跃,并表明FSHR剪接的物种特异性调节在哺乳动物卵巢功能中发挥着不同作用。